Participated · Seed · Oct 2025

Fere AI's core product is an agent that runs continuously and refines its own trading strategy over time using market feedback. The company positions the system as 'self-improving,' enabling users with limited trading experience to rely on automated adaptation rather than manual updates. Fere frames its mission as bringing tools previously reserved for institutional trading desks to retail participants. The startup confirmed a $1.3 million seed raise to advance development but did not disclose a launch timeline, revenue, users, or other operating metrics. It also did not disclose investor identities, a valuation, or prior financing in the announcement. The company highlighted the broader trend of AI agents in crypto and competing product moves by established exchanges, and stated no token has been announced.

Participated · Series C · Jan 2022

FireGen Biomedicals develops core nucleic-acid testing technologies including instruments, chips, extraction systems, PCR devices and integrated sample-to-result solutions. The company emphasizes independent R&D across four foundational domains—nucleic acid, chips, mechanical engineering and software—and has accumulated over a hundred pieces of intellectual property. Its products aim to fully replace imported high-tech components and to bring rapid nucleic acid testing into grassroots medical systems, with current distribution in more than 30 countries including the U.S. and EU. FireGen operates a large GMP facility in Kunshan, Suzhou with P2, PCR, POCT and microbiology labs and single-facility output value of approximately RMB 500–700 million; the plant meets CFDA, U.S. FDA and EU CE registration and production requirements. The company was founded nearly six years ago, is based in Haidian, Zhongguancun (Beijing), and maintains an innovation center with the Chinese Academy of Sciences and deep partnerships with leading hospitals for product translation. Future plans described by management include expanding the joint innovation center with the CAS, deepening collaboration with Peking University People’s Hospital on urine tumor early screening and POCT platforms, and pursuing supply-chain M&A to extend manufacturing and distribution capabilities.

Led · Equity · Aug 2021

VisIC Technologies Ltd. is an Israel-based pioneer designing Gallium Nitride (GaN) power semiconductor devices for electric mobility. Its proprietary D³GaN platform delivers high efficiency, scalability and reliability for 400 V and 800 V EV drivetrains, offering smaller, lighter and more efficient inverters than silicon and at lower cost than SiC alternatives. The company’s current roadmap centers on releasing Gen3 750 V GaN dice and power modules and advancing a Gen4 1,350 V technology to cover the full spectrum of EV designs. Beyond automotive, VisIC also sees demand for its GaN technology in emerging 800 V data-center power systems. Newly secured capital will be directed toward product qualification, supply-chain stabilization and production ramp-up. The recent $26 million Round B financing underscores the market’s confidence in VisIC’s ability to redefine power electronics for next-generation electric vehicles.

Led · Equity · Apr 2020

tZERO operates an SEC-regulated alternative trading system (ATS) and broker-dealer that provides blockchain-based liquidity and trading solutions for private and public assets, cryptocurrencies, and NFTs. The company offers institutional-grade tools for issuers to digitize cap tables and for broker-dealers, institutions, and investors to access private assets on an automated, regulated venue. tZERO is pursuing expanded market infrastructure initiatives, including a joint venture with BOX Digital Markets to launch the Boston Security Token Exchange (BSTX), a regulated blockchain-enabled securities exchange. The firm is a portfolio company of Medici Ventures, whose general partner is affiliated with Pelion Venture Partners; Overstock is a limited partner of Medici Ventures and holds a direct minority interest in tZERO. Management recently announced the appointment of David Goone, formerly ICE Chief Strategy Officer, as tZERO’s CEO effective March 2022, signaling a strategic push toward product and operational scaling. The company said it completed an additional strategic funding round from new and existing investors to support growth and innovation. tZERO develops distributed ledger and smart contract technology to increase efficiency and transparency in capital markets, focusing on tokenizing, trading and settling digital securities. The company is majority owned by Overstock.com and is part of Medici Ventures’ keiretsu. tZERO positions itself as a next-generation capital markets platform and is actively commercializing its fintech and blockchain innovations. It completed a $5 million equity investment from GoldenSand Capital, which the company says will support strategic collaboration and partnership opportunities. GoldenSand has expressed intent to leverage its Asia connections and portfolio assets to pursue synergies with tZERO’s tokenization protocol. The company emphasizes it is not a registered broker-dealer or investment manager and does not provide brokerage or underwriting services. tZERO develops and commercializes FinTech built on blockchain to bring greater efficiency and transparency to capital markets. The company is building securities trading functionality and working on a joint venture with BOX digital Markets to launch a regulated security token exchange. tZERO is conducting a Security Token Offering (STO) and has executed SAFEs in excess of $168 million, with over $95 million funded and roughly 1,000 participants from 30 countries. Proceeds from the STO will be used to build trading capabilities, bolster the team, and support international expansion. tZERO’s leadership frames the GSR investment as validation of its strategy to introduce blockchain to capital markets.

Participated · Series A · Oct 2019

DeepRoute.ai develops end-to-end smart driving solutions centered on its DeepRoute IO model and is a pioneer in deploying end-to-end architecture for robotics via mass-produced passenger vehicles. The company intends to enhance R&D on the frontier DeepRoute IO and develop a next‑generation visual-language-action DeepRoute IO set to launch next year. Since August, approximately 20,000 vehicles integrated with DeepRoute IO have been delivered to customers. DeepRoute.ai plans to release more than 10 additional series models in collaboration with selective OEM clients next year and is exploring a future Robotaxi business. The company also aims to scale global automakers’ collaboration and recruit more AI-native talent. DeepRoute.ai is led by CEO Maxwell Zhou and has offices in Shenzhen, Beijing and Fremont, California. DeepRoute.ai is an international self-driving technology company based in Shenzhen and Fremont, focused on autonomy for urban logistics and robotaxis. Led by CEO Maxwell Zhou, the company develops self-driving systems for robotaxis and medium-duty trucks to improve transit, shipments and freight delivery. Its long-term strategy includes developing medium-duty trucks for urban logistics and growing its robotaxi fleet to more than 150 vehicles by the end of 2021. Operating in Wuhan and Shenzhen, DeepRoute.ai has driven more than 1.2 million miles on public roads and received a Passenger Carry Permit from the California Public Utilities Commission in June. The company intends to use new funding to further R&D, scale automaker collaboration and fleet operations, and expand its team. The report states the company closed a Series B described as totaling more than $300M, though it also notes the round's exact amount was not disclosed. DeepRoute is a full-stack solution provider focused on L4 autonomous driving with a global presence. Its core technology includes an early sensor fusion perception approach called Early fusion, which synchronizes time and location, fuses original sensor data, and integrates output and correlation information across sensors to stabilize detection of dynamic and static objects. The company's planning algorithm uses semantic maps and handles random scenarios to plan feasible and safe routes, timing of turns, lane selection, crossroads decisions and other driving behaviors. DeepRoute's research centers are located in Shenzhen, Beijing and Silicon Valley. The company raised approximately $50 million in a funding round led by Foshun RZ Capital with participation from GoldenSand Capital, Yunqi Partners, Ventech China and Green Pine Capital Partners. It intends to use the proceeds to continue expanding operations and its business reach.